Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteers

Lisa Seitz, Lixia Jin, Manmohan R. Leleti, Devika Ashok, Jenna L. Jeffrey, Aimee Rieger, Renger G. Tiessen, Gerhard Arold, Joanne B.L. Tan, Jay P. Powers,

Investigational New Drugs · 2018 · 64 citations · 14 references

Concepts

References

14